SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention

IS Mahmoud, YB Jarrar, W Alshaer, S Ismail - Biochimie, 2020 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new viral disease that
has gained global attention owing to its ability to provoke community and health-care …

[HTML][HTML] Update of the current knowledge on genetics, evolution, immunopathogenesis, and transmission for coronavirus disease 19 (COVID-19)

K Tizaoui, I Zidi, KH Lee, R Abou Ghayda… - … journal of biological …, 2020 - ncbi.nlm.nih.gov
In December 2019, an acute respiratory disease caused by novel species of coronavirus
(SARS-CoV-2), emerged in China and has spread throughout the world. On 11 th March …

Cellular and molecular pathways of COVID-19 and potential points of therapeutic intervention

JP Hussman - Frontiers in pharmacology, 2020 - frontiersin.org
With the objective of linking early findings relating to the novel SARS-CoV-2 coronavirus
with potentially informative findings from prior research literature and to promote …

Deciphering SARS-CoV-2 virologic and immunologic features

G Lebeau, D Vagner, E Frumence, F Ah-Pine… - International journal of …, 2020 - mdpi.com
Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 and its associated
pathology, COVID-19, have been of particular concerns these last months due to the …

COVID-19: molecular and cellular response

SD Alipoor, E Mortaz, H Jamaati, P Tabarsi… - Frontiers in cellular …, 2021 - frontiersin.org
In late December 2019, a vtiral pneumonia with an unknown agent was reported in Wuhan,
China. A novel coronavirus was identified as the causative agent. Because of the human-to …

New insights of emerging SARS-CoV-2: epidemiology, etiology, clinical features, clinical treatment, and prevention

G Guo, L Ye, K Pan, Y Chen, D Xing, K Yan… - Frontiers in cell and …, 2020 - frontiersin.org
Since the first reports that the novel coronavirus was showing human-to-human transmission
characteristics and asymptomatic cases, the number of patients with associated pneumonia …

Understanding individual SARS-CoV-2 proteins for targeted drug development against COVID-19

J van de Leemput, Z Han - Molecular and cellular biology, 2021 - Taylor & Francis
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the COVID-
19 pandemic, responsible for millions of deaths globally. Even with effective vaccines, SARS …

Pathophysiology and clinical management of coronavirus disease (COVID-19): a mini-review

Y Zhu, L Sharma, D Chang - Frontiers in Immunology, 2023 - frontiersin.org
An unprecedented global pandemic caused by a novel coronavirus named SARS-CoV-2
has created a severe healthcare threat and become one of the biggest challenges to human …

SARS-CoV-2-specific immune response and the pathogenesis of COVID-19

E Gusev, A Sarapultsev, L Solomatina… - International journal of …, 2022 - mdpi.com
The review aims to consolidate research findings on the molecular mechanisms and
virulence and pathogenicity characteristics of coronavirus disease (COVID-19) causative …

The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update

SA Jasim, RS Mahdi, DO Bokov… - Journal of Medical …, 2022 - Wiley Online Library
The precise interaction between the immune system and severe acute respiratory syndrome
coronavirus 2 (SARS‑CoV‑2) is critical in deciphering the pathogenesis of coronavirus …